ヒトパピローマウイルスタンパク質E7の世界市場（～2026年）

• 英文タイトル：Global Human Papillomavirus Protein E7 Market Insights and Forecast to 2026

• レポートコード：MRC2-11QY01431
• 出版社/出版日：QYResearch / 2020年11月20日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、154ページ
• 納品方法：Eメール（納期：2~3日）
• 産業分類：医療、製薬

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ
Enterprise License	￥1,170,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

当調査資料はヒトパピローマウイルスタンパク質E7のグローバル市場について調査・分析したレポートです。種類別（CUE-201、BLSILSB-710c、CerviVax、CUE-101、その他）市場規模、用途別（肛門がん、肺がん、陰茎がん、直腸がん、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。
・調査範囲
・エグゼクティブサマリー
・企業別ヒトパピローマウイルスタンパク質E7の競争状況、市場シェア
・世界のヒトパピローマウイルスタンパク質E7市場：種類別市場規模 2015年-2020年（CUE-201、BLSILSB-710c、CerviVax、CUE-101、その他）
・世界のヒトパピローマウイルスタンパク質E7市場：種類別市場規模予測 2021年-2026年（CUE-201、BLSILSB-710c、CerviVax、CUE-101、その他）
・世界のヒトパピローマウイルスタンパク質E7市場：用途別市場規模 2015年-2020年（肛門がん、肺がん、陰茎がん、直腸がん、その他）
・世界のヒトパピローマウイルスタンパク質E7市場：用途別市場規模予測 2021年-2026年（肛門がん、肺がん、陰茎がん、直腸がん、その他）
・北米のヒトパピローマウイルスタンパク質E7市場分析：米国、カナダ
・ヨーロッパのヒトパピローマウイルスタンパク質E7市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアのヒトパピローマウイルスタンパク質E7市場分析：日本、中国、韓国、インド、オーストラリア、台湾等
・中南米のヒトパピローマウイルスタンパク質E7市場分析：メキシコ、ブラジル、アルゼンチン等
・中東・アフリカのヒトパピローマウイルスタンパク質E7市場分析：トルコ、サウジアラビア、UAE等
・企業情報（企業概要、製品概要、販売量、企業動向）
- 掲載企業（変更可能性あり）：Abion Inc、Advaxis Inc、Bioleaders Corp、BioNTech AG、Cancer Research Technology Ltd、Etubics Corp、Formune SL、Genexine Inc、Hookipa Biotech AG、iBio Inc、Immunovaccine Inc、Inovio Pharmaceuticals Inc、MedImmune LLC、Selecta Biosciences Inc、Touchlight Genetics Ltd、Transgene SA、VLPbio
・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論

Market Analysis and Insights: Global Human Papillomavirus Protein E7 Market
The global Human Papillomavirus Protein E7 market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Human Papillomavirus Protein E7 Scope and Market Size
Human Papillomavirus Protein E7 market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Human Papillomavirus Protein E7 market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Human Papillomavirus Protein E7 market is segmented into
CUE-201
BLSILSB-710c
CerviVax
CUE-101
Others

Segment by Application, the Human Papillomavirus Protein E7 market is segmented into
Anal Cancer
Lung Cancer
Penile Cancer
Rectal Cancer
Others

Regional and Country-level Analysis
The Human Papillomavirus Protein E7 market is analysed and market size information is provided by regions (countries).
The key regions covered in the Human Papillomavirus Protein E7 market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Human Papillomavirus Protein E7 Market Share Analysis
Human Papillomavirus Protein E7 market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Human Papillomavirus Protein E7 business, the date to enter into the Human Papillomavirus Protein E7 market, Human Papillomavirus Protein E7 product introduction, recent developments, etc.

The major vendors covered:
Abion Inc
Advaxis Inc
Bioleaders Corp
BioNTech AG
Cancer Research Technology Ltd
Etubics Corp
Formune SL
Genexine Inc
Hookipa Biotech AG
iBio Inc
Immunovaccine Inc
Inovio Pharmaceuticals Inc
MedImmune LLC
Selecta Biosciences Inc
Touchlight Genetics Ltd
Transgene SA
VLPbio

レポート目次

1 Study Coverage
1.1 Human Papillomavirus Protein E7 Product Introduction
1.2 Market Segments
1.3 Key Human Papillomavirus Protein E7 Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Human Papillomavirus Protein E7 Market Size Growth Rate by Type
1.4.2 CUE-201
1.4.3 BLSILSB-710c
1.4.4 CerviVax
1.4.5 CUE-101
1.4.6 Others
1.5 Market by Application
1.5.1 Global Human Papillomavirus Protein E7 Market Size Growth Rate by Application
1.5.2 Anal Cancer
1.5.3 Lung Cancer
1.5.4 Penile Cancer
1.5.5 Rectal Cancer
1.5.6 Others
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Human Papillomavirus Protein E7 Market Size, Estimates and Forecasts
2.1.1 Global Human Papillomavirus Protein E7 Revenue 2015-2026
2.1.2 Global Human Papillomavirus Protein E7 Sales 2015-2026
2.2 Global Human Papillomavirus Protein E7, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Human Papillomavirus Protein E7 Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Human Papillomavirus Protein E7 Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Human Papillomavirus Protein E7 Competitor Landscape by Players
3.1 Human Papillomavirus Protein E7 Sales by Manufacturers
3.1.1 Human Papillomavirus Protein E7 Sales by Manufacturers (2015-2020)
3.1.2 Human Papillomavirus Protein E7 Sales Market Share by Manufacturers (2015-2020)
3.2 Human Papillomavirus Protein E7 Revenue by Manufacturers
3.2.1 Human Papillomavirus Protein E7 Revenue by Manufacturers (2015-2020)
3.2.2 Human Papillomavirus Protein E7 Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Human Papillomavirus Protein E7 Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Human Papillomavirus Protein E7 Revenue in 2019
3.2.5 Global Human Papillomavirus Protein E7 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Human Papillomavirus Protein E7 Price by Manufacturers
3.4 Human Papillomavirus Protein E7 Manufacturing Base Distribution, Product Types
3.4.1 Human Papillomavirus Protein E7 Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Human Papillomavirus Protein E7 Product Type
3.4.3 Date of International Manufacturers Enter into Human Papillomavirus Protein E7 Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Human Papillomavirus Protein E7 Market Size by Type (2015-2020)
4.1.1 Global Human Papillomavirus Protein E7 Sales by Type (2015-2020)
4.1.2 Global Human Papillomavirus Protein E7 Revenue by Type (2015-2020)
4.1.3 Human Papillomavirus Protein E7 Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Human Papillomavirus Protein E7 Market Size Forecast by Type (2021-2026)
4.2.1 Global Human Papillomavirus Protein E7 Sales Forecast by Type (2021-2026)
4.2.2 Global Human Papillomavirus Protein E7 Revenue Forecast by Type (2021-2026)
4.2.3 Human Papillomavirus Protein E7 Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Human Papillomavirus Protein E7 Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
5.1 Global Human Papillomavirus Protein E7 Market Size by Application (2015-2020)
5.1.1 Global Human Papillomavirus Protein E7 Sales by Application (2015-2020)
5.1.2 Global Human Papillomavirus Protein E7 Revenue by Application (2015-2020)
5.1.3 Human Papillomavirus Protein E7 Price by Application (2015-2020)
5.2 Human Papillomavirus Protein E7 Market Size Forecast by Application (2021-2026)
5.2.1 Global Human Papillomavirus Protein E7 Sales Forecast by Application (2021-2026)
5.2.2 Global Human Papillomavirus Protein E7 Revenue Forecast by Application (2021-2026)
5.2.3 Global Human Papillomavirus Protein E7 Price Forecast by Application (2021-2026)

6 North America
6.1 North America Human Papillomavirus Protein E7 by Country
6.1.1 North America Human Papillomavirus Protein E7 Sales by Country
6.1.2 North America Human Papillomavirus Protein E7 Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Human Papillomavirus Protein E7 Market Facts & Figures by Type
6.3 North America Human Papillomavirus Protein E7 Market Facts & Figures by Application

7 Europe
7.1 Europe Human Papillomavirus Protein E7 by Country
7.1.1 Europe Human Papillomavirus Protein E7 Sales by Country
7.1.2 Europe Human Papillomavirus Protein E7 Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Human Papillomavirus Protein E7 Market Facts & Figures by Type
7.3 Europe Human Papillomavirus Protein E7 Market Facts & Figures by Application

8 Asia Pacific
8.1 Asia Pacific Human Papillomavirus Protein E7 by Region
8.1.1 Asia Pacific Human Papillomavirus Protein E7 Sales by Region
8.1.2 Asia Pacific Human Papillomavirus Protein E7 Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Human Papillomavirus Protein E7 Market Facts & Figures by Type
8.3 Asia Pacific Human Papillomavirus Protein E7 Market Facts & Figures by Application

9 Latin America
9.1 Latin America Human Papillomavirus Protein E7 by Country
9.1.1 Latin America Human Papillomavirus Protein E7 Sales by Country
9.1.2 Latin America Human Papillomavirus Protein E7 Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Human Papillomavirus Protein E7 Market Facts & Figures by Type
9.3 Central & South America Human Papillomavirus Protein E7 Market Facts & Figures by Application

10 Middle East and Africa
10.1 Middle East and Africa Human Papillomavirus Protein E7 by Country
10.1.1 Middle East and Africa Human Papillomavirus Protein E7 Sales by Country
10.1.2 Middle East and Africa Human Papillomavirus Protein E7 Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Human Papillomavirus Protein E7 Market Facts & Figures by Type
10.3 Middle East and Africa Human Papillomavirus Protein E7 Market Facts & Figures by Application

11 Company Profiles
11.1 Abion Inc
11.1.1 Abion Inc Corporation Information
11.1.2 Abion Inc Description and Business Overview
11.1.3 Abion Inc Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Abion Inc Human Papillomavirus Protein E7 Products Offered
11.1.5 Abion Inc Related Developments
11.2 Advaxis Inc
11.2.1 Advaxis Inc Corporation Information
11.2.2 Advaxis Inc Description and Business Overview
11.2.3 Advaxis Inc Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Advaxis Inc Human Papillomavirus Protein E7 Products Offered
11.2.5 Advaxis Inc Related Developments
11.3 Bioleaders Corp
11.3.1 Bioleaders Corp Corporation Information
11.3.2 Bioleaders Corp Description and Business Overview
11.3.3 Bioleaders Corp Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Bioleaders Corp Human Papillomavirus Protein E7 Products Offered
11.3.5 Bioleaders Corp Related Developments
11.4 BioNTech AG
11.4.1 BioNTech AG Corporation Information
11.4.2 BioNTech AG Description and Business Overview
11.4.3 BioNTech AG Sales, Revenue and Gross Margin (2015-2020)
11.4.4 BioNTech AG Human Papillomavirus Protein E7 Products Offered
11.4.5 BioNTech AG Related Developments
11.5 Cancer Research Technology Ltd
11.5.1 Cancer Research Technology Ltd Corporation Information
11.5.2 Cancer Research Technology Ltd Description and Business Overview
11.5.3 Cancer Research Technology Ltd Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Cancer Research Technology Ltd Human Papillomavirus Protein E7 Products Offered
11.5.5 Cancer Research Technology Ltd Related Developments
11.6 Etubics Corp
11.6.1 Etubics Corp Corporation Information
11.6.2 Etubics Corp Description and Business Overview
11.6.3 Etubics Corp Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Etubics Corp Human Papillomavirus Protein E7 Products Offered
11.6.5 Etubics Corp Related Developments
11.7 Formune SL
11.7.1 Formune SL Corporation Information
11.7.2 Formune SL Description and Business Overview
11.7.3 Formune SL Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Formune SL Human Papillomavirus Protein E7 Products Offered
11.7.5 Formune SL Related Developments
11.8 Genexine Inc
11.8.1 Genexine Inc Corporation Information
11.8.2 Genexine Inc Description and Business Overview
11.8.3 Genexine Inc Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Genexine Inc Human Papillomavirus Protein E7 Products Offered
11.8.5 Genexine Inc Related Developments
11.9 Hookipa Biotech AG
11.9.1 Hookipa Biotech AG Corporation Information
11.9.2 Hookipa Biotech AG Description and Business Overview
11.9.3 Hookipa Biotech AG Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Hookipa Biotech AG Human Papillomavirus Protein E7 Products Offered
11.9.5 Hookipa Biotech AG Related Developments
11.10 iBio Inc
11.10.1 iBio Inc Corporation Information
11.10.2 iBio Inc Description and Business Overview
11.10.3 iBio Inc Sales, Revenue and Gross Margin (2015-2020)
11.10.4 iBio Inc Human Papillomavirus Protein E7 Products Offered
11.10.5 iBio Inc Related Developments
11.1 Abion Inc
11.1.1 Abion Inc Corporation Information
11.1.2 Abion Inc Description and Business Overview
11.1.3 Abion Inc Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Abion Inc Human Papillomavirus Protein E7 Products Offered
11.1.5 Abion Inc Related Developments
11.12 Inovio Pharmaceuticals Inc
11.12.1 Inovio Pharmaceuticals Inc Corporation Information
11.12.2 Inovio Pharmaceuticals Inc Description and Business Overview
11.12.3 Inovio Pharmaceuticals Inc Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Inovio Pharmaceuticals Inc Products Offered
11.12.5 Inovio Pharmaceuticals Inc Related Developments
11.13 MedImmune LLC
11.13.1 MedImmune LLC Corporation Information
11.13.2 MedImmune LLC Description and Business Overview
11.13.3 MedImmune LLC Sales, Revenue and Gross Margin (2015-2020)
11.13.4 MedImmune LLC Products Offered
11.13.5 MedImmune LLC Related Developments
11.14 Selecta Biosciences Inc
11.14.1 Selecta Biosciences Inc Corporation Information
11.14.2 Selecta Biosciences Inc Description and Business Overview
11.14.3 Selecta Biosciences Inc Sales, Revenue and Gross Margin (2015-2020)
11.14.4 Selecta Biosciences Inc Products Offered
11.14.5 Selecta Biosciences Inc Related Developments
11.15 Touchlight Genetics Ltd
11.15.1 Touchlight Genetics Ltd Corporation Information
11.15.2 Touchlight Genetics Ltd Description and Business Overview
11.15.3 Touchlight Genetics Ltd Sales, Revenue and Gross Margin (2015-2020)
11.15.4 Touchlight Genetics Ltd Products Offered
11.15.5 Touchlight Genetics Ltd Related Developments
11.16 Transgene SA
11.16.1 Transgene SA Corporation Information
11.16.2 Transgene SA Description and Business Overview
11.16.3 Transgene SA Sales, Revenue and Gross Margin (2015-2020)
11.16.4 Transgene SA Products Offered
11.16.5 Transgene SA Related Developments
11.17 VLPbio
11.17.1 VLPbio Corporation Information
11.17.2 VLPbio Description and Business Overview
11.17.3 VLPbio Sales, Revenue and Gross Margin (2015-2020)
11.17.4 VLPbio Products Offered
11.17.5 VLPbio Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Human Papillomavirus Protein E7 Market Estimates and Projections by Region
12.1.1 Global Human Papillomavirus Protein E7 Sales Forecast by Regions 2021-2026
12.1.2 Global Human Papillomavirus Protein E7 Revenue Forecast by Regions 2021-2026
12.2 North America Human Papillomavirus Protein E7 Market Size Forecast (2021-2026)
12.2.1 North America: Human Papillomavirus Protein E7 Sales Forecast (2021-2026)
12.2.2 North America: Human Papillomavirus Protein E7 Revenue Forecast (2021-2026)
12.2.3 North America: Human Papillomavirus Protein E7 Market Size Forecast by Country (2021-2026)
12.3 Europe Human Papillomavirus Protein E7 Market Size Forecast (2021-2026)
12.3.1 Europe: Human Papillomavirus Protein E7 Sales Forecast (2021-2026)
12.3.2 Europe: Human Papillomavirus Protein E7 Revenue Forecast (2021-2026)
12.3.3 Europe: Human Papillomavirus Protein E7 Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Human Papillomavirus Protein E7 Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Human Papillomavirus Protein E7 Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Human Papillomavirus Protein E7 Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Human Papillomavirus Protein E7 Market Size Forecast by Region (2021-2026)
12.5 Latin America Human Papillomavirus Protein E7 Market Size Forecast (2021-2026)
12.5.1 Latin America: Human Papillomavirus Protein E7 Sales Forecast (2021-2026)
12.5.2 Latin America: Human Papillomavirus Protein E7 Revenue Forecast (2021-2026)
12.5.3 Latin America: Human Papillomavirus Protein E7 Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Human Papillomavirus Protein E7 Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Human Papillomavirus Protein E7 Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Human Papillomavirus Protein E7 Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Human Papillomavirus Protein E7 Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Human Papillomavirus Protein E7 Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Human Papillomavirus Protein E7 Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables
Table 1. Human Papillomavirus Protein E7 Market Segments
Table 2. Ranking of Global Top Human Papillomavirus Protein E7 Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Human Papillomavirus Protein E7 Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of CUE-201
Table 5. Major Manufacturers of BLSILSB-710c
Table 6. Major Manufacturers of CerviVax
Table 7. Major Manufacturers of CUE-101
Table 8. Major Manufacturers of Others
Table 9. Global Human Papillomavirus Protein E7 Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 10. Global Human Papillomavirus Protein E7 Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 11. Global Human Papillomavirus Protein E7 Sales by Regions 2015-2020 (K Pcs)
Table 12. Global Human Papillomavirus Protein E7 Sales Market Share by Regions (2015-2020)
Table 13. Global Human Papillomavirus Protein E7 Revenue by Regions 2015-2020 (US$ Million)
Table 14. Global Human Papillomavirus Protein E7 Sales by Manufacturers (2015-2020) (K Pcs)
Table 15. Global Human Papillomavirus Protein E7 Sales Share by Manufacturers (2015-2020)
Table 16. Global Human Papillomavirus Protein E7 Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 17. Global Human Papillomavirus Protein E7 by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Papillomavirus Protein E7 as of 2019)
Table 18. Human Papillomavirus Protein E7 Revenue by Manufacturers (2015-2020) (US$ Million)
Table 19. Human Papillomavirus Protein E7 Revenue Share by Manufacturers (2015-2020)
Table 20. Key Manufacturers Human Papillomavirus Protein E7 Price (2015-2020) (USD/Pcs)
Table 21. Human Papillomavirus Protein E7 Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Human Papillomavirus Protein E7 Product Type
Table 23. Date of International Manufacturers Enter into Human Papillomavirus Protein E7 Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Human Papillomavirus Protein E7 Sales by Type (2015-2020) (K Pcs)
Table 26. Global Human Papillomavirus Protein E7 Sales Share by Type (2015-2020)
Table 27. Global Human Papillomavirus Protein E7 Revenue by Type (2015-2020) (US$ Million)
Table 28. Global Human Papillomavirus Protein E7 Revenue Share by Type (2015-2020)
Table 29. Human Papillomavirus Protein E7 Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 30. Global Human Papillomavirus Protein E7 Sales by Application (2015-2020) (K Pcs)
Table 31. Global Human Papillomavirus Protein E7 Sales Share by Application (2015-2020)
Table 32. North America Human Papillomavirus Protein E7 Sales by Country (2015-2020) (K Pcs)
Table 33. North America Human Papillomavirus Protein E7 Sales Market Share by Country (2015-2020)
Table 34. North America Human Papillomavirus Protein E7 Revenue by Country (2015-2020) (US$ Million)
Table 35. North America Human Papillomavirus Protein E7 Revenue Market Share by Country (2015-2020)
Table 36. North America Human Papillomavirus Protein E7 Sales by Type (2015-2020) (K Pcs)
Table 37. North America Human Papillomavirus Protein E7 Sales Market Share by Type (2015-2020)
Table 38. North America Human Papillomavirus Protein E7 Sales by Application (2015-2020) (K Pcs)
Table 39. North America Human Papillomavirus Protein E7 Sales Market Share by Application (2015-2020)
Table 40. Europe Human Papillomavirus Protein E7 Sales by Country (2015-2020) (K Pcs)
Table 41. Europe Human Papillomavirus Protein E7 Sales Market Share by Country (2015-2020)
Table 42. Europe Human Papillomavirus Protein E7 Revenue by Country (2015-2020) (US$ Million)
Table 43. Europe Human Papillomavirus Protein E7 Revenue Market Share by Country (2015-2020)
Table 44. Europe Human Papillomavirus Protein E7 Sales by Type (2015-2020) (K Pcs)
Table 45. Europe Human Papillomavirus Protein E7 Sales Market Share by Type (2015-2020)
Table 46. Europe Human Papillomavirus Protein E7 Sales by Application (2015-2020) (K Pcs)
Table 47. Europe Human Papillomavirus Protein E7 Sales Market Share by Application (2015-2020)
Table 48. Asia Pacific Human Papillomavirus Protein E7 Sales by Region (2015-2020) (K Pcs)
Table 49. Asia Pacific Human Papillomavirus Protein E7 Sales Market Share by Region (2015-2020)
Table 50. Asia Pacific Human Papillomavirus Protein E7 Revenue by Region (2015-2020) (US$ Million)
Table 51. Asia Pacific Human Papillomavirus Protein E7 Revenue Market Share by Region (2015-2020)
Table 52. Asia Pacific Human Papillomavirus Protein E7 Sales by Type (2015-2020) (K Pcs)
Table 53. Asia Pacific Human Papillomavirus Protein E7 Sales Market Share by Type (2015-2020)
Table 54. Asia Pacific Human Papillomavirus Protein E7 Sales by Application (2015-2020) (K Pcs)
Table 55. Asia Pacific Human Papillomavirus Protein E7 Sales Market Share by Application (2015-2020)
Table 56. Latin America Human Papillomavirus Protein E7 Sales by Country (2015-2020) (K Pcs)
Table 57. Latin America Human Papillomavirus Protein E7 Sales Market Share by Country (2015-2020)
Table 58. Latin Americaa Human Papillomavirus Protein E7 Revenue by Country (2015-2020) (US$ Million)
Table 59. Latin America Human Papillomavirus Protein E7 Revenue Market Share by Country (2015-2020)
Table 60. Latin America Human Papillomavirus Protein E7 Sales by Type (2015-2020) (K Pcs)
Table 61. Latin America Human Papillomavirus Protein E7 Sales Market Share by Type (2015-2020)
Table 62. Latin America Human Papillomavirus Protein E7 Sales by Application (2015-2020) (K Pcs)
Table 63. Latin America Human Papillomavirus Protein E7 Sales Market Share by Application (2015-2020)
Table 64. Middle East and Africa Human Papillomavirus Protein E7 Sales by Country (2015-2020) (K Pcs)
Table 65. Middle East and Africa Human Papillomavirus Protein E7 Sales Market Share by Country (2015-2020)
Table 66. Middle East and Africa Human Papillomavirus Protein E7 Revenue by Country (2015-2020) (US$ Million)
Table 67. Middle East and Africa Human Papillomavirus Protein E7 Revenue Market Share by Country (2015-2020)
Table 68. Middle East and Africa Human Papillomavirus Protein E7 Sales by Type (2015-2020) (K Pcs)
Table 69. Middle East and Africa Human Papillomavirus Protein E7 Sales Market Share by Type (2015-2020)
Table 70. Middle East and Africa Human Papillomavirus Protein E7 Sales by Application (2015-2020) (K Pcs)
Table 71. Middle East and Africa Human Papillomavirus Protein E7 Sales Market Share by Application (2015-2020)
Table 72. Abion Inc Corporation Information
Table 73. Abion Inc Description and Major Businesses
Table 74. Abion Inc Human Papillomavirus Protein E7 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 75. Abion Inc Product
Table 76. Abion Inc Recent Development
Table 77. Advaxis Inc Corporation Information
Table 78. Advaxis Inc Description and Major Businesses
Table 79. Advaxis Inc Human Papillomavirus Protein E7 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 80. Advaxis Inc Product
Table 81. Advaxis Inc Recent Development
Table 82. Bioleaders Corp Corporation Information
Table 83. Bioleaders Corp Description and Major Businesses
Table 84. Bioleaders Corp Human Papillomavirus Protein E7 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 85. Bioleaders Corp Product
Table 86. Bioleaders Corp Recent Development
Table 87. BioNTech AG Corporation Information
Table 88. BioNTech AG Description and Major Businesses
Table 89. BioNTech AG Human Papillomavirus Protein E7 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 90. BioNTech AG Product
Table 91. BioNTech AG Recent Development
Table 92. Cancer Research Technology Ltd Corporation Information
Table 93. Cancer Research Technology Ltd Description and Major Businesses
Table 94. Cancer Research Technology Ltd Human Papillomavirus Protein E7 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 95. Cancer Research Technology Ltd Product
Table 96. Cancer Research Technology Ltd Recent Development
Table 97. Etubics Corp Corporation Information
Table 98. Etubics Corp Description and Major Businesses
Table 99. Etubics Corp Human Papillomavirus Protein E7 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 100. Etubics Corp Product
Table 101. Etubics Corp Recent Development
Table 102. Formune SL Corporation Information
Table 103. Formune SL Description and Major Businesses
Table 104. Formune SL Human Papillomavirus Protein E7 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 105. Formune SL Product
Table 106. Formune SL Recent Development
Table 107. Genexine Inc Corporation Information
Table 108. Genexine Inc Description and Major Businesses
Table 109. Genexine Inc Human Papillomavirus Protein E7 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 110. Genexine Inc Product
Table 111. Genexine Inc Recent Development
Table 112. Hookipa Biotech AG Corporation Information
Table 113. Hookipa Biotech AG Description and Major Businesses
Table 114. Hookipa Biotech AG Human Papillomavirus Protein E7 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 115. Hookipa Biotech AG Product
Table 116. Hookipa Biotech AG Recent Development
Table 117. iBio Inc Corporation Information
Table 118. iBio Inc Description and Major Businesses
Table 119. iBio Inc Human Papillomavirus Protein E7 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 120. iBio Inc Product
Table 121. iBio Inc Recent Development
Table 122. Immunovaccine Inc Corporation Information
Table 123. Immunovaccine Inc Description and Major Businesses
Table 124. Immunovaccine Inc Human Papillomavirus Protein E7 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 125. Immunovaccine Inc Product
Table 126. Immunovaccine Inc Recent Development
Table 127. Inovio Pharmaceuticals Inc Corporation Information
Table 128. Inovio Pharmaceuticals Inc Description and Major Businesses
Table 129. Inovio Pharmaceuticals Inc Human Papillomavirus Protein E7 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 130. Inovio Pharmaceuticals Inc Product
Table 131. Inovio Pharmaceuticals Inc Recent Development
Table 132. MedImmune LLC Corporation Information
Table 133. MedImmune LLC Description and Major Businesses
Table 134. MedImmune LLC Human Papillomavirus Protein E7 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 135. MedImmune LLC Product
Table 136. MedImmune LLC Recent Development
Table 137. Selecta Biosciences Inc Corporation Information
Table 138. Selecta Biosciences Inc Description and Major Businesses
Table 139. Selecta Biosciences Inc Human Papillomavirus Protein E7 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 140. Selecta Biosciences Inc Product
Table 141. Selecta Biosciences Inc Recent Development
Table 142. Touchlight Genetics Ltd Corporation Information
Table 143. Touchlight Genetics Ltd Description and Major Businesses
Table 144. Touchlight Genetics Ltd Human Papillomavirus Protein E7 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 145. Touchlight Genetics Ltd Product
Table 146. Touchlight Genetics Ltd Recent Development
Table 147. Transgene SA Corporation Information
Table 148. Transgene SA Description and Major Businesses
Table 149. Transgene SA Human Papillomavirus Protein E7 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 150. Transgene SA Product
Table 151. Transgene SA Recent Development
Table 152. VLPbio Corporation Information
Table 153. VLPbio Description and Major Businesses
Table 154. VLPbio Human Papillomavirus Protein E7 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 155. VLPbio Product
Table 156. VLPbio Recent Development
Table 157. Global Human Papillomavirus Protein E7 Sales Forecast by Regions (2021-2026) (K Pcs)
Table 158. Global Human Papillomavirus Protein E7 Sales Market Share Forecast by Regions (2021-2026)
Table 159. Global Human Papillomavirus Protein E7 Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 160. Global Human Papillomavirus Protein E7 Revenue Market Share Forecast by Regions (2021-2026)
Table 161. North America: Human Papillomavirus Protein E7 Sales Forecast by Country (2021-2026) (K Pcs)
Table 162. North America: Human Papillomavirus Protein E7 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 163. Europe: Human Papillomavirus Protein E7 Sales Forecast by Country (2021-2026) (K Pcs)
Table 164. Europe: Human Papillomavirus Protein E7 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 165. Asia Pacific: Human Papillomavirus Protein E7 Sales Forecast by Region (2021-2026) (K Pcs)
Table 166. Asia Pacific: Human Papillomavirus Protein E7 Revenue Forecast by Region (2021-2026) (US$ Million)
Table 167. Latin America: Human Papillomavirus Protein E7 Sales Forecast by Country (2021-2026) (K Pcs)
Table 168. Latin America: Human Papillomavirus Protein E7 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 169. Middle East and Africa: Human Papillomavirus Protein E7 Sales Forecast by Country (2021-2026) (K Pcs)
Table 170. Middle East and Africa: Human Papillomavirus Protein E7 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 171. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 172. Key Challenges
Table 173. Market Risks
Table 174. Main Points Interviewed from Key Human Papillomavirus Protein E7 Players
Table 175. Human Papillomavirus Protein E7 Customers List
Table 176. Human Papillomavirus Protein E7 Distributors List
Table 177. Research Programs/Design for This Report
Table 178. Key Data Information from Secondary Sources
Table 179. Key Data Information from Primary Sources
List of Figures
Figure 1. Human Papillomavirus Protein E7 Product Picture
Figure 2. Global Human Papillomavirus Protein E7 Sales Market Share by Type in 2020 & 2026
Figure 3. CUE-201 Product Picture
Figure 4. BLSILSB-710c Product Picture
Figure 5. CerviVax Product Picture
Figure 6. CUE-101 Product Picture
Figure 7. Others Product Picture
Figure 8. Global Human Papillomavirus Protein E7 Sales Market Share by Application in 2020 & 2026
Figure 9. Anal Cancer
Figure 10. Lung Cancer
Figure 11. Penile Cancer
Figure 12. Rectal Cancer
Figure 13. Others
Figure 14. Human Papillomavirus Protein E7 Report Years Considered
Figure 15. Global Human Papillomavirus Protein E7 Market Size 2015-2026 (US$ Million)
Figure 16. Global Human Papillomavirus Protein E7 Sales 2015-2026 (K Pcs)
Figure 17. Global Human Papillomavirus Protein E7 Market Size Market Share by Region: 2020 Versus 2026
Figure 18. Global Human Papillomavirus Protein E7 Sales Market Share by Region (2015-2020)
Figure 19. Global Human Papillomavirus Protein E7 Sales Market Share by Region in 2019
Figure 20. Global Human Papillomavirus Protein E7 Revenue Market Share by Region (2015-2020)
Figure 21. Global Human Papillomavirus Protein E7 Revenue Market Share by Region in 2019
Figure 22. Global Human Papillomavirus Protein E7 Sales Share by Manufacturer in 2019
Figure 23. The Top 10 and 5 Players Market Share by Human Papillomavirus Protein E7 Revenue in 2019
Figure 24. Human Papillomavirus Protein E7 Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 25. Global Human Papillomavirus Protein E7 Sales Market Share by Type (2015-2020)
Figure 26. Global Human Papillomavirus Protein E7 Sales Market Share by Type in 2019
Figure 27. Global Human Papillomavirus Protein E7 Revenue Market Share by Type (2015-2020)
Figure 28. Global Human Papillomavirus Protein E7 Revenue Market Share by Type in 2019
Figure 29. Global Human Papillomavirus Protein E7 Market Share by Price Range (2015-2020)
Figure 30. Global Human Papillomavirus Protein E7 Sales Market Share by Application (2015-2020)
Figure 31. Global Human Papillomavirus Protein E7 Sales Market Share by Application in 2019
Figure 32. Global Human Papillomavirus Protein E7 Revenue Market Share by Application (2015-2020)
Figure 33. Global Human Papillomavirus Protein E7 Revenue Market Share by Application in 2019
Figure 34. North America Human Papillomavirus Protein E7 Sales Growth Rate 2015-2020 (K Pcs)
Figure 35. North America Human Papillomavirus Protein E7 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 36. North America Human Papillomavirus Protein E7 Sales Market Share by Country in 2019
Figure 37. North America Human Papillomavirus Protein E7 Revenue Market Share by Country in 2019
Figure 38. U.S. Human Papillomavirus Protein E7 Sales Growth Rate (2015-2020) (K Pcs)
Figure 39. U.S. Human Papillomavirus Protein E7 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. Canada Human Papillomavirus Protein E7 Sales Growth Rate (2015-2020) (K Pcs)
Figure 41. Canada Human Papillomavirus Protein E7 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 42. North America Human Papillomavirus Protein E7 Market Share by Type in 2019
Figure 43. North America Human Papillomavirus Protein E7 Market Share by Application in 2019
Figure 44. Europe Human Papillomavirus Protein E7 Sales Growth Rate 2015-2020 (K Pcs)
Figure 45. Europe Human Papillomavirus Protein E7 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 46. Europe Human Papillomavirus Protein E7 Sales Market Share by Country in 2019
Figure 47. Europe Human Papillomavirus Protein E7 Revenue Market Share by Country in 2019
Figure 48. Germany Human Papillomavirus Protein E7 Sales Growth Rate (2015-2020) (K Pcs)
Figure 49. Germany Human Papillomavirus Protein E7 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. France Human Papillomavirus Protein E7 Sales Growth Rate (2015-2020) (K Pcs)
Figure 51. France Human Papillomavirus Protein E7 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. U.K. Human Papillomavirus Protein E7 Sales Growth Rate (2015-2020) (K Pcs)
Figure 53. U.K. Human Papillomavirus Protein E7 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Italy Human Papillomavirus Protein E7 Sales Growth Rate (2015-2020) (K Pcs)
Figure 55. Italy Human Papillomavirus Protein E7 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Russia Human Papillomavirus Protein E7 Sales Growth Rate (2015-2020) (K Pcs)
Figure 57. Russia Human Papillomavirus Protein E7 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Europe Human Papillomavirus Protein E7 Market Share by Type in 2019
Figure 59. Europe Human Papillomavirus Protein E7 Market Share by Application in 2019
Figure 60. Asia Pacific Human Papillomavirus Protein E7 Sales Growth Rate 2015-2020 (K Pcs)
Figure 61. Asia Pacific Human Papillomavirus Protein E7 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 62. Asia Pacific Human Papillomavirus Protein E7 Sales Market Share by Region in 2019
Figure 63. Asia Pacific Human Papillomavirus Protein E7 Revenue Market Share by Region in 2019
Figure 64. China Human Papillomavirus Protein E7 Sales Growth Rate (2015-2020) (K Pcs)
Figure 65. China Human Papillomavirus Protein E7 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Japan Human Papillomavirus Protein E7 Sales Growth Rate (2015-2020) (K Pcs)
Figure 67. Japan Human Papillomavirus Protein E7 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. South Korea Human Papillomavirus Protein E7 Sales Growth Rate (2015-2020) (K Pcs)
Figure 69. South Korea Human Papillomavirus Protein E7 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. India Human Papillomavirus Protein E7 Sales Growth Rate (2015-2020) (K Pcs)
Figure 71. India Human Papillomavirus Protein E7 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Australia Human Papillomavirus Protein E7 Sales Growth Rate (2015-2020) (K Pcs)
Figure 73. Australia Human Papillomavirus Protein E7 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Taiwan Human Papillomavirus Protein E7 Sales Growth Rate (2015-2020) (K Pcs)
Figure 75. Taiwan Human Papillomavirus Protein E7 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Indonesia Human Papillomavirus Protein E7 Sales Growth Rate (2015-2020) (K Pcs)
Figure 77. Indonesia Human Papillomavirus Protein E7 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Thailand Human Papillomavirus Protein E7 Sales Growth Rate (2015-2020) (K Pcs)
Figure 79. Thailand Human Papillomavirus Protein E7 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Malaysia Human Papillomavirus Protein E7 Sales Growth Rate (2015-2020) (K Pcs)
Figure 81. Malaysia Human Papillomavirus Protein E7 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Philippines Human Papillomavirus Protein E7 Sales Growth Rate (2015-2020) (K Pcs)
Figure 83. Philippines Human Papillomavirus Protein E7 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Vietnam Human Papillomavirus Protein E7 Sales Growth Rate (2015-2020) (K Pcs)
Figure 85. Vietnam Human Papillomavirus Protein E7 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 86. Asia Pacific Human Papillomavirus Protein E7 Market Share by Type in 2019
Figure 87. Asia Pacific Human Papillomavirus Protein E7 Market Share by Application in 2019
Figure 88. Latin America Human Papillomavirus Protein E7 Sales Growth Rate 2015-2020 (K Pcs)
Figure 89. Latin America Human Papillomavirus Protein E7 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 90. Latin America Human Papillomavirus Protein E7 Sales Market Share by Country in 2019
Figure 91. Latin America Human Papillomavirus Protein E7 Revenue Market Share by Country in 2019
Figure 92. Mexico Human Papillomavirus Protein E7 Sales Growth Rate (2015-2020) (K Pcs)
Figure 93. Mexico Human Papillomavirus Protein E7 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Brazil Human Papillomavirus Protein E7 Sales Growth Rate (2015-2020) (K Pcs)
Figure 95. Brazil Human Papillomavirus Protein E7 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Argentina Human Papillomavirus Protein E7 Sales Growth Rate (2015-2020) (K Pcs)
Figure 97. Argentina Human Papillomavirus Protein E7 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 98. Latin America Human Papillomavirus Protein E7 Market Share by Type in 2019
Figure 99. Latin America Human Papillomavirus Protein E7 Market Share by Application in 2019
Figure 100. Middle East and Africa Human Papillomavirus Protein E7 Sales Growth Rate 2015-2020 (K Pcs)
Figure 101. Middle East and Africa Human Papillomavirus Protein E7 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 102. Middle East and Africa Human Papillomavirus Protein E7 Sales Market Share by Country in 2019
Figure 103. Middle East and Africa Human Papillomavirus Protein E7 Revenue Market Share by Country in 2019
Figure 104. Turkey Human Papillomavirus Protein E7 Sales Growth Rate (2015-2020) (K Pcs)
Figure 105. Turkey Human Papillomavirus Protein E7 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Saudi Arabia Human Papillomavirus Protein E7 Sales Growth Rate (2015-2020) (K Pcs)
Figure 107. Saudi Arabia Human Papillomavirus Protein E7 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. U.A.E Human Papillomavirus Protein E7 Sales Growth Rate (2015-2020) (K Pcs)
Figure 109. U.A.E Human Papillomavirus Protein E7 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 110. Middle East and Africa Human Papillomavirus Protein E7 Market Share by Type in 2019
Figure 111. Middle East and Africa Human Papillomavirus Protein E7 Market Share by Application in 2019
Figure 112. North America Human Papillomavirus Protein E7 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 113. North America Human Papillomavirus Protein E7 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Europe Human Papillomavirus Protein E7 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 115. Europe Human Papillomavirus Protein E7 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Asia Pacific Human Papillomavirus Protein E7 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 117. Asia Pacific Human Papillomavirus Protein E7 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Latin America Human Papillomavirus Protein E7 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 119. Latin America Human Papillomavirus Protein E7 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Middle East and Africa Human Papillomavirus Protein E7 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 121. Middle East and Africa Human Papillomavirus Protein E7 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 122. Porter's Five Forces Analysis
Figure 123. Channels of Distribution
Figure 124. Distributors Profiles
Figure 125. Bottom-up and Top-down Approaches for This Report
Figure 126. Data Triangulation
Figure 127. Key Executives Interviewed

以下、関連資料のご紹介

ヒトパピローマウイルスタンパク質E6の世界市場（～2026年）

Global Human Papillomavirus Protein E6 Market Insights and Forecast to 2026
MRC2-11QY01430 2020年11月20日 111Pages
当調査資料はヒトパピローマウイルスタンパク質E6のグローバル市場について調査・分析したレポートです。種類別（ABN-301、BVAC-C、ETBX-041、GX-188E、その他）市場規模、用途別（子宮頸部上皮内腫瘍、肺がん、中咽頭がん、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイ...

ヒトパピローマウイルス（HPV）ワクチンの世界市場（～2026年）

Global Human Papillomavirus (HPV) Vaccines Market Insights and Forecast to 2026
MRC2-11QY01429 2020年11月20日 117Pages
当調査資料はヒトパピローマウイルス（HPV）ワクチンのグローバル市場について調査・分析したレポートです。種類別（2価ワクチン、4価ワクチン）市場規模、用途別（研究所、製薬・バイオテクノロジー企業、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、...

ヒトパピローマウイルスワクチンの世界市場（～2026年）

Global Human Papillomavirus Vaccine Market Insights and Forecast to 2026
MRC2-11QY01432 2020年11月20日 113Pages
当調査資料はヒトパピローマウイルスワクチンのグローバル市場について調査・分析したレポートです。種類別（二価、四価、一価）市場規模、用途別（医師、卸売業者、医師販売代理店、政府機関、公的・私的同盟）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、...

組換えヒトアルブミンの世界市場（～2026年）

Global Recombinant Human Albumin Market Size, Status and Forecast 2020-2026
MRC2-11QY04470 2020年11月20日 98Pages
当調査資料は組換えヒトアルブミンのグローバル市場について調査・分析したレポートです。種類別（OsrHSA、ScrHSA）市場規模、用途別（細胞培養培地、医療サプリメント、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、...

ヒトパラインフルエンザウイルス（HPIV）診断診断の世界市場（～2026年）

Global Human Parainfluenza Viruses Diagnostics Market Size, Status and Forecast 2020-2026
MRC2-11QY12257 2020年11月25日 93Pages
当調査資料はヒトパラインフルエンザウイルス（HPIV）診断診断のグローバル市場について調査・分析したレポートです。種類別（HPV検査、フォローアップHPV検査、共同検査）市場規模、用途別（子宮頸がん検診、膣がん検診、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス...

ヒト間葉系幹細胞（hMSC）の世界市場（～2026年）

Global Human Mesenchymal Stem Cells (hMSC) Market Size, Status and Forecast 2020-2026
MRC2-11QY12252 2020年11月25日 99Pages
当調査資料はヒト間葉系幹細胞（hMSC）のグローバル市場について調査・分析したレポートです。種類別（臍帯マトリックスhMSC、骨髄hMSC、脂肪組織hMSC、その他）市場規模、用途別（医療、研究、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、...

ヒト成長ホルモン（hGH）の世界市場（～2026年）

Global Human Growth Hormone (hGH) Market Size, Status and Forecast 2020-2026
MRC2-11QY12248 2020年11月25日 97Pages
当調査資料はヒト成長ホルモン（hGH）のグローバル市場について調査・分析したレポートです。種類別（粉末、溶剤）市場規模、用途別（成長ホルモン欠乏症、ターナー症候群、特発性低身長、プラダー・ウィリー症候群（PWS）、低出生体重児、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フラン...

ヒトパピローマウイルス（HPV）治療薬の世界市場（～2026年）

Global Human Papillomaviru Therapeutics Market Size, Status and Forecast 2020-2026
MRC2-11QY12256 2020年11月25日 93Pages
当調査資料はヒトパピローマウイルス（HPV）治療薬のグローバル市場について調査・分析したレポートです。種類別（免疫調節剤、角質溶解剤、抗腫瘍剤、シネカテキン）市場規模、用途別（生殖器疣贅、生殖器癌、疣冗長表皮異形成症、口腔乳頭腫、中咽頭癌、喉頭乳頭腫症、その他）市場規模、地域別（北米、米国、カナダ、...

ヒト免疫不全ウイルス（HIV）の世界市場（～2026年）

Global Human Immunodeficiency Virus(HIV) Market Size, Status and Forecast 2020-2026
MRC2-11QY12251 2020年11月25日 95Pages
当調査資料はヒト免疫不全ウイルス（HIV）のグローバル市場について調査・分析したレポートです。種類別（診断、治療）市場規模、用途別（病院、外来手術センター、診断センター、在宅医療施設、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本...

ヒトマイクロバイオーム治療薬の世界市場（～2026年）

Global Human Microbiome Therapeutics Market Size, Status and Forecast 2020-2026
MRC2-11QY12254 2020年11月25日 95Pages
当調査資料はヒトマイクロバイオーム治療薬のグローバル市場について調査・分析したレポートです。種類別（FMT、マイクロバイオーム薬）市場規模、用途別（クロストリジウム・ディフィシル、クローン病、炎症性腸疾患、糖尿病、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、...

ヒトパピローマウイルスタンパク質E6の世界市場（～2026年） Market Analysis and Insights: Global Human Papillomavirus Protein E6 Market The global Human Papillomavirus Protein E6 market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Human Papillomavirus Protein E6 Scope and Market Si…
ヒトパピローマウイルス（HPV）ワクチンの世界市場（～2026年） Market Analysis and Insights: Global Human Papillomavirus (HPV) Vaccines Market The global Human Papillomavirus (HPV) Vaccines market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Human Papillomavirus (HPV) Vaccines Scope a…
ヒトパピローマウイルスワクチンの世界市場（～2026年） Human papilloma virus (HPV) vaccine is a vaccine that prevents infection by certain types of human papillomavirus. Market Analysis and Insights: Global Human Papillomavirus Vaccine Market The global Human Papillomavirus Vaccine market size is projected to reach US$ 2220.7 million by 2026, from US$ 2…
ヒトパラインフルエンザウイルス（HPIV）診断診断の世界市場（～2026年） Human Papillomaviruses (HPV) are members of papillomaviridae family a group of more than 150 related viruses. These are specifically known as papillomaviruses because of some of its types give rise to a wart or papilloma which are benign growths. Some of them are also associated with certain cancers…
ヒトパピローマウイルス（HPV）治療薬の世界市場（～2026年） Market Analysis and Insights: Global Human Papillomaviru Therapeutics Market The global Human Papillomaviru Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Human Papillomaviru Therapeutics Scope and Market…